Welcome To
Acadia Broadcasting NewsThe Latest and Greatest ContentYour Trusted Local Source


Pfizer BioNTech COVID-19 Booster Approved for Children 5-11

By Tara Clow Aug 19, 2022 | 2:45 PM

Nenad Stojkovic / CC

A new COVID-19 booster option for young children.

Canada’s chief public health officer Dr. Theresa Tam revealed the details during a news conference today, “Health Canada has authorized the 10 micrograms Pfizer-BioNTech COVID-19 booster for children aged five to 11 years.”

She says this booster dose provides a great option to restore protection for this age group, especially for those who are at high risk for severe illness.

(Photo: CPAC)

Dr. Tam says, “National Advisory Committee on Immunization  (NACI) recommends that children five to 11 years of age who have an underlying medical condition and are at a high risk of severe illness due to COVID 19, including children who are immunocompromised should be offered a first booster dose of the 10 microgram BioNTech COVID-19COVID-19 vaccine at least six months after completion of a primary series of the vaccine.”

For other children in that same age group, NACI recommends a booster dose “may be offered” after completing the two doses of the COVID-19 vaccine.

Dr. Tam says the COVID-19 vaccine should be a top priority in preparation for potential future waves in the fall.


Leave a Reply